Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02)

NCT00507741 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Endometrial Cancer

Interventions

DRUG: Vintafolide
DRUG: Ertafolide

Sponsor

Endocyte